organ growth perform across
view view favor highlight particularli strong
organ growth across ri consult segment view
good momentum room margin expans unit
jlt acquisit remain track close spring
remain posit merit deal long term
estim rais ep estim
mainli reflect result minor tweak estim
also revis ep forecast
factor slightli reduc revenu share
buy-back assumpt assum share buyback
estim yet incorpor jlt acquisit
manag expect slightli dilut ep first
year close deal expect close spring
oper ep vs pro-forma ep last year
adjust impact beat estim
consensu estim better-than-anticip risk insur
servic segment margin partli off-set softer-than-expect
item note organ growth strong pretti much across
unit oliv wyman guy carpent produc
organ growth albeit manag temper outlook
unit manag note jlt integr plan track
expect cost synergi million compani note
share buyback unlik earlier next year
resum jlt deal close besid jlt deal compani also
announc two marsh agenc acquisit quarter mercer
unit announc two acquisit invest consult area
million combin revenu reduc debt leverag follow
closur jlt deal emphasi manag note
plenti capac marsh agenc
area focu
posit strong organ growth across board ri segment
margin nice big quarter billion
jlt acquisit notabl activ mercer
neg consult segment margin soft due part
tough comparison share repurchas unlik jlt
deal close fx hedg charg carri valu write-down
debt cap
valu usd unless otherwis note
price prior trade day market close estimate unless otherwis note
bloomberg capit market estim upside/downside/target
base case assum adjust ep estim
consist commiss fee growth excess
around top-lin growth assumpt
organ base case assum slightli improv
trend solid good intern growth
forecast adjust oper margin
assum solid margin expans strong top-lin growth
year-end ep ebitda forecast close
upsid scenario assum commiss fee
growth driven better-than-expect penetr
global
econom climat quicker-than-expect traction
marsh agenc scenario realiz addit
basi point margin improv stem
subdu cost environ solid oper leverag
aforement revenu gain upsid scenario
incorpor multipl approxim
ep ebitda forecast
downsid scenario assum commiss
fee growth could reflect challeng
econom new busi environ rel
expect brokerag consult unit
assum basi point margin deterior rel
expect due higher-than-expect cost
environ less favor oper leverag
multipl approxim ep
see marsh mclennan good spot
compani continu build strong new
busi momentum growth across platform
potenti revenu opportun includ penetr
emerg market stabil improv europ
rise demand consult servic new custom win
healthcar exchang platform start
see leverag benefit organ growth pick
comfort margin continu expand
modestli even steadi organ growth consult
unit see inconsist result expect better
result shortli sector valuat risen recent
month find share attract global revenu
earn growth potenti
gain traction intern compani continu
grow significantli emerg market countri
key foreign market success build presenc
faster-grow region insur penetr rate
low rise
strength insur unit see sever reason
strong momentum marsh guy carpent
continu driven higher usag services/new product
offer increas penetr marsh agenc
room margin expans compani shown
good track record realiz bottom-lin leverag
good organ sale growth trend see persist
jlt acquisit jlt acquisit expect
dilut near term like long-term prospect
potenti upsides/risk invest thesi
good expens disciplin coupl rise cost
environ certain insur broker think
mid-single-digit organ growth rate higher need
drive margin materi higher sale slip believ
margin expans could difficult achiev
currenc risk given global natur
book busi compani subject polit
currenc execut risk associ oper
across number differ platform
consult segment result consult segment
econom sensit see fluctuat due
chang project activ econom uncertainti
could weigh unit result
takeaway quarter
overal top bottom line quarter risk insur servic ri unit
ri organ growth advanc clip core canada region
marsh mix gener anoth quarter good growth believ
perform stack well vs peer suggest out-performance s/canada
region quarter trend mix latin america asia
pacif off-set flat organ revenu emea marsh emea busi fairli
larg marsh mix region continu see lacklust trend like
driven continu soft econom condit guy carpent organ growth
strong quarter unit continu perform well
expect despit stagnant reinsur price climat manag guid
temper organ growth rate guy carpent given tough y/i
comparison last year storm-rel reinstat premium riss oper
margin improv significantli basi point pro-forma basi
rebound y/i margin declin consider better
strong top-lin show consult unit albeit margin remain constrain
organ growth consult segment rebound driven
strong organ growth oliv wyman quarter given manag
guid organ growth declin oliv wyman would surmis
project work may shown earlier expect impress
oliv wyman organ growth rate indic strong economi
suggest busi use discretionari servic mercer organ
growth decent defin benefit consult administr area
organ growth remain drag overal result think mercer well
posit leverag capabl deleg invest workday career talent
health/priv exchang remain good oper environ
consult margin pressur basi point y/i
albeit declin forecast due tough year-ago comparison
anticip consult unit margin expand basi point
jlt acquisit close track spring close manag note jlt
acquisit announc mid septemb track close spring
 ftc alreadi termin hart scott rodino wait period relat
approv mmc/jlt merger although regulatori approv need
particularli europ uk also jlt sharehold vote merger
schedul novemb manag note jlt integr plan
track reiter acquisit expect modestli dilut mmc
adjust ep year neutral year accret year recal manag
guid synergi million transact dont view much
reach
 activ remain brisk apart billion jlt acquisit still
engag front particularli activ quarter mercer
announc acquisit invest consult compani summit strategi group
invest altern consult wealth manag oper
pavilion combin revenu two acquisit total
million expand mercer invest deleg invest asset presenc
mercer seen strong growth recent year marsh agenc unit also announc
two acquisit minnesota maryland-bas broker louisiana-bas
eusti insur benefit mm annual revenu manag
express plenti capac addit marsh agenc
unit area focu
rais ep estim mainli reflect
result minor tweak estim also revis ep
forecast factor slightli reduc revenu
share buy-back assumpt assum share buyback
estim yet incorpor jlt acquisit manag expect
slightli dilut ep first year close deal expect close
spring
marsh mclennan report adjust oper ep vs pro-forma ep
last year adjust impact beat estim
consensu estim better-than-anticip risk insur servic segment
margin partli off-set softer-than-expect consult segment oper margin
report ep includ million invest loss chang
valu fx contract also million charg relat reduc carri
valu alexand forb unit partli off-set million gain sale
softwar busi also exclud adjust ep
minor interest expens total million vs million line estim
weight averag share count margin vs last year third quarter
report tax rate came adjust tax rate estim
tax rate aid million discret item ex benefit
manag guid tax rate fx slight drag top bottom
line similar impact expect
compani report capit market estim
pro-forma basi mmc companywid adjust oper margin basi
point estim compens benefit cost total
revenu pro-forma basi basi point pro-forma
oper expens total revenu also basi point
risk ice segment forecastvari guy risk uranc segment oliv wyman number pro-forma reflect impact urance/nonlif
total pro-forma companywid revenu rose billion essenti line
estim ri unit report revenu ahead estim
off-set consult segment revenu trail expect fx one percentag
point headwind compar two percentag point headwind june quarter
manag expect invest incom immateri
risk insur servic segment highlight
organ revenu growth rate risk insur servic ri unit
consist organ growth pace slightli better
total ri revenu billion better billion
marsh unit organ growth vs point short
estim marsh latin america unit led way organ growth
 canada territori solid asia pacif organ growth deceler
emea organ growth flat quarter
guy carpent report one best organ growth quarter year
organ growth consider forecast biggest sourc
strength specialti well facult
pro-forma basi ri unit adjust oper margin improv basi
point estim
compani report capit market estim
organ revenu consult unit improv
outpac estim consult revenu increas billion shi
billion assumpt
mercer organ revenu vs line
estim manag relat servic report highest organ growth
mercer organ growth health rose defin benefit
 servic segment organ revenu adjust oper segment organ revenu adjust oper organ revenu adjust oper number pro-forma reflect impact urance/nonlif
consult administr revenu fell albeit better organ
revenu declin seen
oliv wyman organ revenu grew impress quarter
estim improv declin
pro-forma basi consult unit adjust oper margin deterior
basi point weaker estim mercer variabl
compens adjust last year creat tough comparison year
big deal quarter announc acquisit jlt billion
all-cash deal largest insur brokerag deal record strateg reason
acquisit includ buy jlt talent acquisit track record broaden
specialti categori increas geograph footprint sever intern
territori includ uk australia deal track close spring
mercer announc acquisit missouri-bas invest consult
compani summit strategi group billion asset advis
compani mercer unit also announc acquisit invest
altern consult wealth manag oper pavilion
quarter summit pavilion combin annual revenu total million
marsh agenc unit announc two acquisit earli quarter minnesota
maryland-bas broker earli octob mmc agenc unit announc
acquisit louisiana-bas eusti insur benefit mm annual
compani spent million share buyback estim
million lower million run rate first two quarter
year believ impend jlt acquisit factor behind
somewhat slower buy-back pace
 cash equival declin sequenti million roughli
total debt around million sequenti billion although
debt/cap ratio move due reduct sharehold
equiti increas borrow capac credit facil million
billion also repaid million senior note come due octob
goodwil intang asset rose sequenti end septemb billion
follow merger agreement jlt fitch affirm mmc credit
rate reduc outlook neg
price target base ep ebitda/shar forecast
multipl repres premium peer averag multipl consist
mmc recent trade rang perspect slight premium valuat warrant
strength platform grow intern presenc much-improv balanc sheet
opportun out-performance top- bottom-lin perspect
expect integr larg jlt acquisit key valuat driver price
target support outperform recommend
risk rate price target
risk price target rate includ follow
insur price deterior global basi remain weak extend
period time
risk associ weak global economi softer corpor discretionari spend
risk insur servic consult segment
manag turnov inabl retain attract key produc time
industry-wid pressur overal insur brokerag commiss rate
global exposur currenc risk polit risk chang tax landscap foreign
integr risk associ acquisit includ build-out marsh
advers rule litig higher-than-expect claim
unexpect chang regulatori system unit state within
marsh mclennan compani one world largest profession servic firm
revenu excess billion global reach extend
countri marsh mclennan provid broad array servic includ insur
numer relat serv compani risk insur servic segment
includ marsh guy carpent special insur reinsur broker
placement well numer risk manag analyt servic compani
consult segment consist oliv wyman group mercer provid human
resourc consult manag consult outsourc variou consulting-rel
million except per share data
compens benefit
incom continu oper
discontinu oper net tax
note result pro-forma reflect impact
compani report capit market estim
